Literature DB >> 19815815

Chylomicronemia elicits atherosclerosis in mice--brief report.

Michael M Weinstein1, Liya Yin, Yiping Tu, Xuping Wang, Xiaohui Wu, Lawrence W Castellani, Rosemary L Walzem, Aldons J Lusis, Loren G Fong, Anne P Beigneux, Stephen G Young.   

Abstract

OBJECTIVE: The risk of atherosclerosis in the setting of chylomicronemia has been a topic of debate. In this study, we examined susceptibility to atherosclerosis in Gpihbp1-deficient mice (Gpihbp1(-/-)), which manifest severe chylomicronemia as a result of defective lipolysis. METHODS AND
RESULTS: Gpihbp1(-/-) mice on a chow diet have plasma triglyceride and cholesterol levels of 2812+/-209 and 319+/-27 mg/dL, respectively. Even though nearly all of the lipids were contained in large lipoproteins (50 to 135 nm), the mice developed progressive aortic atherosclerosis. In other experiments, we found that both Gpihbp1-deficient "apo-B48-only" mice and Gpihbp1-deficient "apo-B100-only" mice manifest severe chylomicronemia. Thus, GPIHBP1 is required for the processing of both apo-B48- and apo-B100-containing lipoproteins.
CONCLUSIONS: Chylomicronemia causes atherosclerosis in mice. Also, we found that GPIHBP1 is required for the lipolytic processing of both apo-B48- and apo-B100-containing lipoproteins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19815815      PMCID: PMC2796285          DOI: 10.1161/ATVBAHA.109.196329

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  9 in total

1.  Adenovirus-mediated rescue of lipoprotein lipase-deficient mice. Lipolysis of triglyceride-rich lipoproteins is essential for high density lipoprotein maturation in mice.

Authors:  J G Strauss; S Frank; D Kratky; G Hämmerle; A Hrzenjak; G Knipping; A von Eckardstein; G M Kostner; R Zechner
Journal:  J Biol Chem       Date:  2001-06-29       Impact factor: 5.157

2.  Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100.

Authors:  M M Véniant; V Pierotti; D Newland; C M Cham; D A Sanan; R L Walzem; S G Young
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

3.  Triglycerides and coronary heart disease revisited (again).

Authors:  Michael H Criqui
Journal:  Ann Intern Med       Date:  2007-09-18       Impact factor: 25.391

4.  Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene.

Authors:  P Benlian; J L De Gennes; L Foubert; H Zhang; S E Gagné; M Hayden
Journal:  N Engl J Med       Date:  1996-09-19       Impact factor: 91.245

5.  Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons.

Authors:  Anne P Beigneux; Brandon S J Davies; Peter Gin; Michael M Weinstein; Emily Farber; Xin Qiao; Franklin Peale; Stuart Bunting; Rosemary L Walzem; Jinny S Wong; William S Blaner; Zhi-Ming Ding; Kristan Melford; Nuttaporn Wongsiriroj; Xiao Shu; Fred de Sauvage; Robert O Ryan; Loren G Fong; André Bensadoun; Stephen G Young
Journal:  Cell Metab       Date:  2007-04       Impact factor: 27.287

6.  Large lipoproteins are excluded from the arterial wall in diabetic cholesterol-fed rabbits.

Authors:  B G Nordestgaard; D B Zilversmit
Journal:  J Lipid Res       Date:  1988-11       Impact factor: 5.922

7.  Why does the gut choose apolipoprotein B48 but not B100 for chylomicron formation?

Authors:  Chun-Min Lo; Brian K Nordskog; Andromeda M Nauli; Shuqin Zheng; Sarah B Vonlehmden; Qing Yang; Dana Lee; Larry L Swift; Nicholas O Davidson; Patrick Tso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-11-15       Impact factor: 4.052

8.  Spontaneous atherosclerosis in aged lipoprotein lipase-deficient mice with severe hypertriglyceridemia on a normal chow diet.

Authors:  Xiaohong Zhang; Rong Qi; Xunde Xian; Fei Yang; Michael Blackstein; Xuming Deng; Jianglin Fan; Colin Ross; Joanna Karasinska; Michael R Hayden; George Liu
Journal:  Circ Res       Date:  2007-11-21       Impact factor: 17.367

9.  Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase.

Authors:  Anne P Beigneux; Remco Franssen; André Bensadoun; Peter Gin; Kristan Melford; Jorge Peter; Rosemary L Walzem; Michael M Weinstein; Brandon S J Davies; Jan A Kuivenhoven; John J P Kastelein; Loren G Fong; Geesje M Dallinga-Thie; Stephen G Young
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-03-19       Impact factor: 8.311

  9 in total
  27 in total

1.  Obstructive sleep apnea and effects of continuous positive airway pressure on triglyceride-rich lipoprotein metabolism.

Authors:  Luciano F Drager; Thauany M Tavoni; Vanessa M Silva; Raul D Santos; Rodrigo P Pedrosa; Luiz A Bortolotto; Carmen G Vinagre; Vsevolod Y Polotsky; Geraldo Lorenzi-Filho; Raul C Maranhao
Journal:  J Lipid Res       Date:  2018-04-08       Impact factor: 5.922

2.  Regulating intestinal function to reduce atherogenic lipoproteins.

Authors:  M Mahmood Hussain; Tung Ming Leung; Liye Zhou; Sarah Abu-Merhi
Journal:  Clin Lipidol       Date:  2013-08-01

3.  High-resolution imaging of dietary lipids in cells and tissues by NanoSIMS analysis.

Authors:  Haibo Jiang; Chris N Goulbourne; Angelica Tatar; Kirsten Turlo; Daniel Wu; Anne P Beigneux; Chris R M Grovenor; Loren G Fong; Stephen G Young
Journal:  J Lipid Res       Date:  2014-08-20       Impact factor: 5.922

Review 4.  Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 and the intravascular processing of triglyceride-rich lipoproteins.

Authors:  O Adeyo; C N Goulbourne; A Bensadoun; A P Beigneux; L G Fong; S G Young
Journal:  J Intern Med       Date:  2012-11-01       Impact factor: 8.989

Review 5.  The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight.

Authors:  Geesje M Dallinga-Thie; Remco Franssen; Hans L Mooij; Maartje E Visser; H Carlijne Hassing; Frank Peelman; John J P Kastelein; Miklós Péterfy; Max Nieuwdorp
Journal:  Atherosclerosis       Date:  2009-12-29       Impact factor: 5.162

6.  Unexpected expression pattern for glycosylphosphatidylinositol-anchored HDL-binding protein 1 (GPIHBP1) in mouse tissues revealed by positron emission tomography scanning.

Authors:  Tove Olafsen; Stephen G Young; Brandon S J Davies; Anne P Beigneux; Vania E Kenanova; Constance Voss; Glen Young; Koon-Pong Wong; Richard H Barnes; Yiping Tu; Michael M Weinstein; Chika Nobumori; Sung-Cheng Huang; Ira J Goldberg; André Bensadoun; Anna M Wu; Loren G Fong
Journal:  J Biol Chem       Date:  2010-09-30       Impact factor: 5.157

7.  Transcriptome-wide RNA sequencing analysis of rat skeletal muscle feed arteries. I. Impact of obesity.

Authors:  Nathan T Jenkins; Jaume Padilla; Pamela K Thorne; Jeffrey S Martin; R Scott Rector; J Wade Davis; M Harold Laughlin
Journal:  J Appl Physiol (1985)       Date:  2014-01-16

Review 8.  Biochemistry and pathophysiology of intravascular and intracellular lipolysis.

Authors:  Stephen G Young; Rudolf Zechner
Journal:  Genes Dev       Date:  2013-03-01       Impact factor: 11.361

Review 9.  Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline.

Authors:  Lars Berglund; John D Brunzell; Anne C Goldberg; Ira J Goldberg; Frank Sacks; Mohammad Hassan Murad; Anton F H Stalenhoef
Journal:  J Clin Endocrinol Metab       Date:  2012-09       Impact factor: 5.958

Review 10.  GPIHBP1 and Plasma Triglyceride Metabolism.

Authors:  Loren G Fong; Stephen G Young; Anne P Beigneux; André Bensadoun; Monika Oberer; Haibo Jiang; Michael Ploug
Journal:  Trends Endocrinol Metab       Date:  2016-05-14       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.